Home > Accompany innovation > Incubation, entrepreneurship and research > Labels > GenoTher earns biocluster label
In May 2023 following its call for expression of interest, the French National Research Agency recognized excellence in gene therapy with its accreditation of GenoTher as a biocluster of the France 2030 plan. GenoTher is the brainchild of its founding members: Genethon, Genopole, AP-HP, Inserm, the University of Évry-Paris Saclay, Spark Therapeutics and Yposkesi. Genopole’s contribution to GenoTher will involve the creation & mutualization of technological platforms, support for business creation, and accompaniment for training programs.
GenoTher will strengthen France’s leadership in Europe for the development and production of gene therapies, a sector vital to health independence. The awarding of the label is a major step in the creation of an unprecedented ecosystem for Europe aimed at surmounting the scientific, technological and economic challenges inherent to innovative therapies.